Ποια είναι η τιμή για Synmosa Biopharma Corporation (4114)

Η τιμή για Synmosa Biopharma Corporation (4114) είναι $0.94761103

Ποια είναι η κεφαλαιοποίηση αγοράς για Synmosa Biopharma Corporation (4114)

Η κεφαλαιοποίηση αγοράς για Synmosa Biopharma Corporation (4114) είναι $511.40M

Synmosa Biopharma Corporation (4114) Δείκτης P/S

Synmosa Biopharma Corporation, established in Taipei, Taiwan, in 1980, operates as a dedicated specialty pharmaceutical enterprise. The company manages the entire lifecycle of pharmaceutical and healthcare products, from research and development to manufacturing, marketing, and distribution, primarily serving the Taiwanese market under its proprietary Synmosa brand. Its diverse product portfolio addresses key therapeutic categories, including cardiovascular health, respiratory conditions, urology, sex hormone treatments, and oncology. These offerings are available in various formats such as effervescent tablets, granules, nasal sprays, metered-dose inhalers, hormonal preparations, and other specialized forms. Beyond its proprietary products, Synmosa also extends its expertise through contract manufacturing services. The company maintains a significant international presence, exporting its goods to numerous countries including South Africa, China, Hong Kong, Thailand, Singapore, Malaysia, Vietnam, Myanmar, Cambodia, Peru, Costa Rica, and Nicaragua.

Έτος	P/S Ratio	Αλλαγή
Δεν υπάρχουν αρκετά δεδομένα για τις παρεχόμενες ημερομηνίες.

Έτος

P/S Ratio

Αλλαγή

Δεν υπάρχουν αρκετά δεδομένα για τις παρεχόμενες ημερομηνίες.

Εταιρεία	P/S Ratio	Διαφορά P/S Ratio	Χώρα
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	7.73	-	IN
Galderma Group AG GALD.SW	-	-	CH

Εταιρεία

P/S Ratio

Διαφορά P/S Ratio

Χώρα